The global Biologics Contract Development and Manufacturing Organization(CDMO) market size was estimated at USD 11310 million in 2024 and is projected to reach USD 28697.66 million by 2032, exhibiting a CAGR of 10.90% during the forecast period.
North America Biologics Contract Development and Manufacturing Organization(CDMO) market size was estimated at USD 3523.47 million in 2024, at a CAGR of 9.34% during the forecast period of 2025 through 2032.
Report Overview
In this emerging in the form of cooperation, biological medicine industry further extended to the biological agents in the form of outsourcing cooperation contract development and manufacturing organization (CDMO) mode, the CDMO from preclinical studies and clinical trials to commercial production stage and the enterprise research and development, procurement, production, such as depth of the whole supply chain system docking, provide enterprises with innovative technology research and development and large-scale production services, in the higher value-added technology output instead of the pure output capacity.
This report provides a deep insight into the global Biologics Contract Development and Manufacturing Organization(CDMO) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biologics Contract Development and Manufacturing Organization(CDMO) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biologics Contract Development and Manufacturing Organization(CDMO) market in any manner.
Global Biologics Contract Development and Manufacturing Organization(CDMO) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Lonza
- Hansen
- Boehringer Ingelheim BioXcellence
- Thermo Fisher Scientific
- Samsung BioLogics
- AGC Biologics
- Catalent
- Wuxi Biologics
Market Segmentation (by Type)
- Biologics Contract Development Services
- Biologics Contract Manufacturing Services
Market Segmentation (by Application)
- Big Pharma
- Small Pharma
- Generic Pharma
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Biologics Contract Development and Manufacturing Organization(CDMO) Market
- Overview of the regional outlook of the Biologics Contract Development and Manufacturing Organization(CDMO) Market:
FAQs on the Global Biologics CDMO Market (2024-2032)
1. What is the projected market size of the Biologics CDMO industry by 2032?
- The global Biologics Contract Development and Manufacturing Organization (CDMO) market is projected to reach USD 28,697.66 million by 2032, growing at a CAGR of 10.90% from 2024 to 2032.
2. What was the market value of the Biologics CDMO industry in 2024?
- The estimated market size of the Biologics CDMO industry in 2024 was USD 11,310 million.
3. What factors are driving the growth of the Biologics CDMO market?
Key growth drivers include:
- Increasing demand for biopharmaceuticals and personalized medicine
- Rising outsourcing trends in pharmaceutical manufacturing
- Advancements in bioprocessing technologies
- Growing investment in biologics and biosimilars development
4. What challenges does the Biologics CDMO industry face?
Some challenges include:
- High capital investment required for biologics production
- Regulatory complexities in different regions
- Supply chain disruptions impacting raw material availability
- Competition among CDMOs for capacity and expertise
5. Which regions are leading the Biologics CDMO market growth?
- The North American and European markets are leading due to established biotech hubs, strong regulatory frameworks, and high investments in R&D. However, Asia-Pacific is emerging as a high-growth region due to cost-effective manufacturing and expanding biopharma capabilities.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
Customization of the Report
- In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
- Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
- Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biologics Contract Development and Manufacturing Organization(CDMO) Market and its likely evolution in the short to mid-term, and long term.
- Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
- Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
- Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
- Chapter 9 shares the main producing countries of Biologics Contract Development and Manufacturing Organization(CDMO), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
- Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
- Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
- Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
- Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Biologics Contract Development and Manufacturing Organization(CDMO)
1.2 Key Market Segments
1.2.1 Biologics Contract Development and Manufacturing Organization(CDMO) Segment by Type
1.2.2 Biologics Contract Development and Manufacturing Organization(CDMO) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Biologics Contract Development and Manufacturing Organization(CDMO) Market Overview
2.1 Global Market Overview
2.1.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Biologics Contract Development and Manufacturing Organization(CDMO) Market Competitive Landscape
3.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales by Manufacturers (2019-2025)
3.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Manufacturers (2019-2025)
3.3 Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biologics Contract Development and Manufacturing Organization(CDMO) Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Biologics Contract Development and Manufacturing Organization(CDMO) Sales Sites, Area Served, Product Type
3.6 Biologics Contract Development and Manufacturing Organization(CDMO) Market Competitive Situation and Trends
3.6.1 Biologics Contract Development and Manufacturing Organization(CDMO) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biologics Contract Development and Manufacturing Organization(CDMO) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Biologics Contract Development and Manufacturing Organization(CDMO) Industry Chain Analysis
4.1 Biologics Contract Development and Manufacturing Organization(CDMO) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Biologics Contract Development and Manufacturing Organization(CDMO) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Biologics Contract Development and Manufacturing Organization(CDMO) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Type (2019-2025)
6.3 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Market Share by Type (2019-2025)
6.4 Global Biologics Contract Development and Manufacturing Organization(CDMO) Price by Type (2019-2025)
7 Biologics Contract Development and Manufacturing Organization(CDMO) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Sales by Application (2019-2025)
7.3 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (M USD) by Application (2019-2025)
7.4 Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales Growth Rate by Application (2019-2025)
8 Biologics Contract Development and Manufacturing Organization(CDMO) Market Consumption by Region
8.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales by Region
8.1.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales by Region
8.1.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Region
8.2 North America
8.2.1 North America Biologics Contract Development and Manufacturing Organization(CDMO) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biologics Contract Development and Manufacturing Organization(CDMO) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biologics Contract Development and Manufacturing Organization(CDMO) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Biologics Contract Development and Manufacturing Organization(CDMO) Market Production by Region
9.1 Global Production of Biologics Contract Development and Manufacturing Organization(CDMO) by Region (2019-2025)
9.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Region (2019-2025)
9.3 Global Biologics Contract Development and Manufacturing Organization(CDMO) Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Biologics Contract Development and Manufacturing Organization(CDMO) Production
9.4.1 North America Biologics Contract Development and Manufacturing Organization(CDMO) Production Growth Rate (2019-2025)
9.4.2 North America Biologics Contract Development and Manufacturing Organization(CDMO) Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Production
9.5.1 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Production Growth Rate (2019-2025)
9.5.2 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Biologics Contract Development and Manufacturing Organization(CDMO) Production (2019-2025)
9.6.1 Japan Biologics Contract Development and Manufacturing Organization(CDMO) Production Growth Rate (2019-2025)
9.6.2 Japan Biologics Contract Development and Manufacturing Organization(CDMO) Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Biologics Contract Development and Manufacturing Organization(CDMO) Production (2019-2025)
9.7.1 China Biologics Contract Development and Manufacturing Organization(CDMO) Production Growth Rate (2019-2025)
9.7.2 China Biologics Contract Development and Manufacturing Organization(CDMO) Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Lonza
10.1.1 Lonza Biologics Contract Development and Manufacturing Organization(CDMO) Basic Information
10.1.2 Lonza Biologics Contract Development and Manufacturing Organization(CDMO) Product Overview
10.1.3 Lonza Biologics Contract Development and Manufacturing Organization(CDMO) Product Market Performance
10.1.4 Lonza Business Overview
10.1.5 Lonza Biologics Contract Development and Manufacturing Organization(CDMO) SWOT Analysis
10.1.6 Lonza Recent Developments
10.2 Hansen
10.2.1 Hansen Biologics Contract Development and Manufacturing Organization(CDMO) Basic Information
10.2.2 Hansen Biologics Contract Development and Manufacturing Organization(CDMO) Product Overview
10.2.3 Hansen Biologics Contract Development and Manufacturing Organization(CDMO) Product Market Performance
10.2.4 Hansen Business Overview
10.2.5 Hansen Biologics Contract Development and Manufacturing Organization(CDMO) SWOT Analysis
10.2.6 Hansen Recent Developments
10.3 Boehringer Ingelheim BioXcellence
10.3.1 Boehringer Ingelheim BioXcellence Biologics Contract Development and Manufacturing Organization(CDMO) Basic Information
10.3.2 Boehringer Ingelheim BioXcellence Biologics Contract Development and Manufacturing Organization(CDMO) Product Overview
10.3.3 Boehringer Ingelheim BioXcellence Biologics Contract Development and Manufacturing Organization(CDMO) Product Market Performance
10.3.4 Boehringer Ingelheim BioXcellence Biologics Contract Development and Manufacturing Organization(CDMO) SWOT Analysis
10.3.5 Boehringer Ingelheim BioXcellence Business Overview
10.3.6 Boehringer Ingelheim BioXcellence Recent Developments
10.4 Thermo Fisher Scientific
10.4.1 Thermo Fisher Scientific Biologics Contract Development and Manufacturing Organization(CDMO) Basic Information
10.4.2 Thermo Fisher Scientific Biologics Contract Development and Manufacturing Organization(CDMO) Product Overview
10.4.3 Thermo Fisher Scientific Biologics Contract Development and Manufacturing Organization(CDMO) Product Market Performance
10.4.4 Thermo Fisher Scientific Business Overview
10.4.5 Thermo Fisher Scientific Recent Developments
10.5 Samsung BioLogics
10.5.1 Samsung BioLogics Biologics Contract Development and Manufacturing Organization(CDMO) Basic Information
10.5.2 Samsung BioLogics Biologics Contract Development and Manufacturing Organization(CDMO) Product Overview
10.5.3 Samsung BioLogics Biologics Contract Development and Manufacturing Organization(CDMO) Product Market Performance
10.5.4 Samsung BioLogics Business Overview
10.5.5 Samsung BioLogics Recent Developments
10.6 AGC Biologics
10.6.1 AGC Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Basic Information
10.6.2 AGC Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Product Overview
10.6.3 AGC Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Product Market Performance
10.6.4 AGC Biologics Business Overview
10.6.5 AGC Biologics Recent Developments
10.7 Catalent
10.7.1 Catalent Biologics Contract Development and Manufacturing Organization(CDMO) Basic Information
10.7.2 Catalent Biologics Contract Development and Manufacturing Organization(CDMO) Product Overview
10.7.3 Catalent Biologics Contract Development and Manufacturing Organization(CDMO) Product Market Performance
10.7.4 Catalent Business Overview
10.7.5 Catalent Recent Developments
10.8 Wuxi Biologics
10.8.1 Wuxi Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Basic Information
10.8.2 Wuxi Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Product Overview
10.8.3 Wuxi Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Product Market Performance
10.8.4 Wuxi Biologics Business Overview
10.8.5 Wuxi Biologics Recent Developments
11 Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast by Region
11.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Forecast
11.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Forecast by Country
11.2.3 Asia Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Forecast by Region
11.2.4 South America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Biologics Contract Development and Manufacturing Organization(CDMO) by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Biologics Contract Development and Manufacturing Organization(CDMO) by Type (2025-2032)
12.1.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Biologics Contract Development and Manufacturing Organization(CDMO) by Type (2025-2032)
12.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast by Application (2025-2032)
12.2.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales (K Units) Forecast by Application
12.2.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Comparison by Region (M USD)
Table 5. Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) as of 2022)
Table 10. Global Market Biologics Contract Development and Manufacturing Organization(CDMO) Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Biologics Contract Development and Manufacturing Organization(CDMO) Sales Sites and Area Served
Table 12. Manufacturers Biologics Contract Development and Manufacturing Organization(CDMO) Product Type
Table 13. Global Biologics Contract Development and Manufacturing Organization(CDMO) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biologics Contract Development and Manufacturing Organization(CDMO)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biologics Contract Development and Manufacturing Organization(CDMO) Market Challenges
Table 22. Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales by Type (K Units)
Table 23. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (M USD)
Table 24. Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales (K Units) by Type (2019-2025)
Table 25. Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Type (2019-2025)
Table 26. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (M USD) by Type (2019-2025)
Table 27. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Share by Type (2019-2025)
Table 28. Global Biologics Contract Development and Manufacturing Organization(CDMO) Price (USD/Unit) by Type (2019-2025)
Table 29. Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales (K Units) by Application
Table 30. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application
Table 31. Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales by Application (2019-2025) & (K Units)
Table 32. Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Application (2019-2025)
Table 33. Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales by Application (2019-2025) & (M USD)
Table 34. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Application (2019-2025)
Table 35. Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales Growth Rate by Application (2019-2025)
Table 36. Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales by Region (2019-2025) & (K Units)
Table 37. Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Region (2019-2025)
Table 38. North America Biologics Contract Development and Manufacturing Organization(CDMO) Sales by Country (2019-2025) & (K Units)
Table 39. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Sales by Region (2019-2025) & (K Units)
Table 41. South America Biologics Contract Development and Manufacturing Organization(CDMO) Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Biologics Contract Development and Manufacturing Organization(CDMO) Sales by Region (2019-2025) & (K Units)
Table 43. Global Biologics Contract Development and Manufacturing Organization(CDMO) Production (K Units) by Region (2019-2025)
Table 44. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Region (2019-2025)
Table 46. Global Biologics Contract Development and Manufacturing Organization(CDMO) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Biologics Contract Development and Manufacturing Organization(CDMO) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Biologics Contract Development and Manufacturing Organization(CDMO) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Biologics Contract Development and Manufacturing Organization(CDMO) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. Lonza Biologics Contract Development and Manufacturing Organization(CDMO) Basic Information
Table 52. Lonza Biologics Contract Development and Manufacturing Organization(CDMO) Product Overview
Table 53. Lonza Biologics Contract Development and Manufacturing Organization(CDMO) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. Lonza Business Overview
Table 55. Lonza Biologics Contract Development and Manufacturing Organization(CDMO) SWOT Analysis
Table 56. Lonza Recent Developments
Table 57. Hansen Biologics Contract Development and Manufacturing Organization(CDMO) Basic Information
Table 58. Hansen Biologics Contract Development and Manufacturing Organization(CDMO) Product Overview
Table 59. Hansen Biologics Contract Development and Manufacturing Organization(CDMO) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Hansen Business Overview
Table 61. Hansen Biologics Contract Development and Manufacturing Organization(CDMO) SWOT Analysis
Table 62. Hansen Recent Developments
Table 63. Boehringer Ingelheim BioXcellence Biologics Contract Development and Manufacturing Organization(CDMO) Basic Information
Table 64. Boehringer Ingelheim BioXcellence Biologics Contract Development and Manufacturing Organization(CDMO) Product Overview
Table 65. Boehringer Ingelheim BioXcellence Biologics Contract Development and Manufacturing Organization(CDMO) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Boehringer Ingelheim BioXcellence Biologics Contract Development and Manufacturing Organization(CDMO) SWOT Analysis
Table 67. Boehringer Ingelheim BioXcellence Business Overview
Table 68. Boehringer Ingelheim BioXcellence Recent Developments
Table 69. Thermo Fisher Scientific Biologics Contract Development and Manufacturing Organization(CDMO) Basic Information
Table 70. Thermo Fisher Scientific Biologics Contract Development and Manufacturing Organization(CDMO) Product Overview
Table 71. Thermo Fisher Scientific Biologics Contract Development and Manufacturing Organization(CDMO) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Thermo Fisher Scientific Business Overview
Table 73. Thermo Fisher Scientific Recent Developments
Table 74. Samsung BioLogics Biologics Contract Development and Manufacturing Organization(CDMO) Basic Information
Table 75. Samsung BioLogics Biologics Contract Development and Manufacturing Organization(CDMO) Product Overview
Table 76. Samsung BioLogics Biologics Contract Development and Manufacturing Organization(CDMO) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. Samsung BioLogics Business Overview
Table 78. Samsung BioLogics Recent Developments
Table 79. AGC Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Basic Information
Table 80. AGC Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Product Overview
Table 81. AGC Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. AGC Biologics Business Overview
Table 83. AGC Biologics Recent Developments
Table 84. Catalent Biologics Contract Development and Manufacturing Organization(CDMO) Basic Information
Table 85. Catalent Biologics Contract Development and Manufacturing Organization(CDMO) Product Overview
Table 86. Catalent Biologics Contract Development and Manufacturing Organization(CDMO) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Catalent Business Overview
Table 88. Catalent Recent Developments
Table 89. Wuxi Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Basic Information
Table 90. Wuxi Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Product Overview
Table 91. Wuxi Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Wuxi Biologics Business Overview
Table 93. Wuxi Biologics Recent Developments
Table 94. Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales Forecast by Region (2025-2032) & (K Units)
Table 95. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Forecast by Region (2025-2032) & (M USD)
Table 96. North America Biologics Contract Development and Manufacturing Organization(CDMO) Sales Forecast by Country (2025-2032) & (K Units)
Table 97. North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Forecast by Country (2025-2032) & (M USD)
Table 98. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Sales Forecast by Country (2025-2032) & (K Units)
Table 99. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Forecast by Country (2025-2032) & (M USD)
Table 100. Asia Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Sales Forecast by Region (2025-2032) & (K Units)
Table 101. Asia Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Forecast by Region (2025-2032) & (M USD)
Table 102. South America Biologics Contract Development and Manufacturing Organization(CDMO) Sales Forecast by Country (2025-2032) & (K Units)
Table 103. South America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Forecast by Country (2025-2032) & (M USD)
Table 104. Middle East and Africa Biologics Contract Development and Manufacturing Organization(CDMO) Consumption Forecast by Country (2025-2032) & (Units)
Table 105. Middle East and Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Forecast by Country (2025-2032) & (M USD)
Table 106. Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales Forecast by Type (2025-2032) & (K Units)
Table 107. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Forecast by Type (2025-2032) & (M USD)
Table 108. Global Biologics Contract Development and Manufacturing Organization(CDMO) Price Forecast by Type (2025-2032) & (USD/Unit)
Table 109. Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales (K Units) Forecast by Application (2025-2032)
Table 110. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Biologics Contract Development and Manufacturing Organization(CDMO)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (M USD), 2019-2032
Figure 5. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (M USD) (2019-2032)
Figure 6. Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (M USD)
Figure 11. Biologics Contract Development and Manufacturing Organization(CDMO) Sales Share by Manufacturers in 2023
Figure 12. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Share by Manufacturers in 2023
Figure 13. Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Biologics Contract Development and Manufacturing Organization(CDMO) Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biologics Contract Development and Manufacturing Organization(CDMO) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Type
Figure 18. Sales Market Share of Biologics Contract Development and Manufacturing Organization(CDMO) by Type (2019-2025)
Figure 19. Sales Market Share of Biologics Contract Development and Manufacturing Organization(CDMO) by Type in 2023
Figure 20. Market Size Share of Biologics Contract Development and Manufacturing Organization(CDMO) by Type (2019-2025)
Figure 21. Market Size Market Share of Biologics Contract Development and Manufacturing Organization(CDMO) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Application
Figure 24. Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Application (2019-2025)
Figure 25. Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Application in 2023
Figure 26. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Application (2019-2025)
Figure 27. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Application in 2023
Figure 28. Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales Growth Rate by Application (2019-2025)
Figure 29. Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Region (2019-2025)
Figure 30. North America Biologics Contract Development and Manufacturing Organization(CDMO) Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Country in 2023
Figure 32. U.S. Biologics Contract Development and Manufacturing Organization(CDMO) Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Biologics Contract Development and Manufacturing Organization(CDMO) Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Biologics Contract Development and Manufacturing Organization(CDMO) Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Country in 2023
Figure 37. Germany Biologics Contract Development and Manufacturing Organization(CDMO) Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Biologics Contract Development and Manufacturing Organization(CDMO) Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Biologics Contract Development and Manufacturing Organization(CDMO) Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Biologics Contract Development and Manufacturing Organization(CDMO) Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Biologics Contract Development and Manufacturing Organization(CDMO) Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Region in 2023
Figure 44. China Biologics Contract Development and Manufacturing Organization(CDMO) Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Biologics Contract Development and Manufacturing Organization(CDMO) Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Biologics Contract Development and Manufacturing Organization(CDMO) Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Biologics Contract Development and Manufacturing Organization(CDMO) Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Biologics Contract Development and Manufacturing Organization(CDMO) Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Biologics Contract Development and Manufacturing Organization(CDMO) Sales and Growth Rate (K Units)
Figure 50. South America Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Country in 2023
Figure 51. Brazil Biologics Contract Development and Manufacturing Organization(CDMO) Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Biologics Contract Development and Manufacturing Organization(CDMO) Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Biologics Contract Development and Manufacturing Organization(CDMO) Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Biologics Contract Development and Manufacturing Organization(CDMO) Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Biologics Contract Development and Manufacturing Organization(CDMO) Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Biologics Contract Development and Manufacturing Organization(CDMO) Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Biologics Contract Development and Manufacturing Organization(CDMO) Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Biologics Contract Development and Manufacturing Organization(CDMO) Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Biologics Contract Development and Manufacturing Organization(CDMO) Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Biologics Contract Development and Manufacturing Organization(CDMO) Production Market Share by Region (2019-2025)
Figure 62. North America Biologics Contract Development and Manufacturing Organization(CDMO) Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Biologics Contract Development and Manufacturing Organization(CDMO) Production (K Units) Growth Rate (2019-2025)
Figure 65. China Biologics Contract Development and Manufacturing Organization(CDMO) Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share Forecast by Type (2025-2032)
Figure 70. Global Biologics Contract Development and Manufacturing Organization(CDMO) Sales Forecast by Application (2025-2032)
Figure 71. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share Forecast by Application (2025-2032)
